A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study. (Q33387755)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study. |
scientific article |
Statements
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study (English)
Dimitrios Bafaloukos
Dimitrios Pectasides
Pavlos Papakostas
Helena Linardou
Gerasimos Aravantinos
Aristotelis Bamias
Eleni Timotheadou
Thomas Makatsoris
Epaminondas Samantas
Evangelos Briasoulis
Christos Christodoulou
Christos Papadimitriou
Paris Kosmidis
George Fountzilas
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference